Bristol-Myers Squibb Co
XETRA:BRM

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
XETRA:BRM
Watchlist
Price: 45.675 EUR -0.7% Market Closed
Market Cap: 92.6B EUR

Wall Street
Price Targets

BRM Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRM is 47.165 EUR with a low forecast of 28.523 EUR and a high forecast of 60.919 EUR.

Lowest
Price Target
28.523 EUR
38% Downside
Average
Price Target
47.165 EUR
3% Upside
Highest
Price Target
60.919 EUR
33% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets
4886
ASKA Pharmaceutical Holdings Co Ltd
25% Upside
4568
Daiichi Sankyo Co Ltd
68% Upside
LQDA
Liquidia Corp
43% Upside
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
19% Upside
2096
Simcere Pharmaceutical Group Ltd
46% Upside
CONCORDBIO
Concord Biotech Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 4 years is -4%.

7%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bristol-Myers Squibb Co

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 4 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Bristol-Myers Squibb Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BRM's stock price target?
Price Target
47.165 EUR

According to Wall Street analysts, the average 1-year price target for BRM is 47.165 EUR with a low forecast of 28.523 EUR and a high forecast of 60.919 EUR.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 7%. The projected CAGR for the next 4 years is -4%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 4%. The projected CAGR for the next 4 years is 5%.

Back to Top